SPC494

Sugemalimab

  • Status:
    Umsókn
  • Application date:
    6.1.2025
  • Application published:
    15.2.2025
  • Medicine name:
    Cejemly
  • Medicine for children:
    No

Timeline

Today
6.1.2025Application
15.2.2025Publication

Marketing license

    • Foreign authorization number:
      EU/1/24/1833
    • Date:
      24.7.2024

    Owner

    • Name:
      Wuxi Biologics (Shanghai) Co. Ltd.
    • Address:
      288 Fute Zhong Road Waigaoqiao Free Trade Zone, Shanghai 200131 CN
    • Name:
      Wuxi Biologics Ireland Limited
    • Address:
      Mullagharlin, Dundalk, Co Louth A91 X56F IE

    Agent

    • Name:
      Árnason Faktor ehf.
    • Address:
      Guðríðarstíg 2-4, 113 Reykjavík

    Patent

    Upload documents